Periodic update on transaction details related to Philips’ share repurchases

September 16, 2016

Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) today reported the transaction details related to the repurchases of its own common shares made in the period from September 9, 2016 up to and including September 15, 2016. 

 

These repurchases were made under the EUR 1.5 billion share repurchase program for capital reduction purposes and the repurchase program to cover long term incentive and employee share purchase plans. Further details can be found in the table below and via this link.

 

Date
Total number of repurchased shares
Weighted average purchased price (EUR)
September 2, 2016
37,000
26.2181
September 5, 2016
100,000
26.6170
September 6, 2016
100,000
26.3780
September 7, 2016
50,000
26.3133
September 8, 2016
300,000
25.7921

For further information, please contact:

Ben Zwirs

Philips Group Communications

Tel.: +31 6 15213446

E-mail: ben.zwirs@philips.com


Vanessa Bruinsma-Kleijkers

Philips Investor Relations

Tel.: +31 20 5977447

E-mail: investor.relations@philips.com

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. The company, headquartered in the Netherlands, is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips’ health technology portfolio generated 2015 sales of EUR 16.8 billion and employs approximately 69,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.